TRIM6 facilitates SARS‐CoV‐2 proliferation by catalyzing the K29‐typed ubiquitination of NP to enhance the ability to bind viral genomes
Journal of Medical Virology · 2024-03 · 96 (3)
DOI: 10.1002/jmv.29531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 22.03.2024. Verfasst von Jian Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, School of Medicine, Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Thir…. Hauptthemen laut MEDLINE: COVID-19, Genome, Viral, SARS-CoV-2, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China.
Abstract (Originalsprache)
The Nucleocapsid Protein (NP) of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is not only the core structural protein required for viral packaging, but also participates in the regulation of viral replication, and its post‐translational modifications such as phosphorylation have been shown to be an important strategy for regulating virus proliferation. Our previous work identified NP could be ubiquitinated, as confirmed by two independent studies. But the function of NP ubiquitination is currently unknown. In this study, we first pinpointed TRIM6 as the E3 ubiquitin ligase responsible for NP ubiquitination, binding to NP's CTD via its RING and B‐box‐CCD domains. TRIM6 promotes the K29‐typed polyubiquitination of NP at K102, K347, and K361 residues, increasing its binding to viral genomic RNA. Consistently, functional experiments such as the use of the reverse genetic tool trVLP model and gene knockout of TRIM6 further confirmed that blocking the ubiquitination of NP by TRIM6 significantly inhibited the proliferation of SARS‐CoV‐2. Notably, the NP of coronavirus is relatively conserved, and the NP of SARS‐CoV can also be ubiquitinated by TRIM6, indicating that NP could be a broad‐spectrum anti‐coronavirus target. These findings shed light on the intricate interaction between SARS‐CoV‐2 and the host, potentially opening new opportunities for COVID‐19 therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital, School of Medicine, Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Southern University of Science and Technology, Sh…
- Guangzhou Laboratory, Guangzhou Medical University, Guangzhou, China.
- Department of Microbiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
ORCID-Profile: Zheng Zhang
Förderung
- National Key Research and Development Program of China
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Guangdong Science and Technology Plan Project
- Shenzhen Science and Technology Program
- Natural Science Research Project of Anhui Educational Committee
Zitieren
APA
Zhou, J., Zhou, Y., Wei, X. F., Fan, L., Gao, X., Li, Y., Wu, Y., Feng, W., Shen, X., Liu, L., Xu, G., & Zhang, Z. (2024). TRIM6 facilitates SARS‐CoV‐2 proliferation by catalyzing the K29‐typed ubiquitination of NP to enhance the ability to bind viral genomes. Journal of Medical Virology, 96(3). https://doi.org/10.1002/jmv.29531
Vancouver
Zhou J, Zhou Y, Wei XF, Fan L, Gao X, Li Y, et al. TRIM6 facilitates SARS‐CoV‐2 proliferation by catalyzing the K29‐typed ubiquitination of NP to enhance the ability to bind viral genomes. Journal of Medical Virology. 2024;96(3). doi:10.1002/jmv.29531
BibTeX
@article{Zhou2024,
author = {Zhou, Jian and Zhou, Yuzheng and Wei, Xia-Fei and Fan, Lujie and Gao, Xiang and Li, Yunfei and Wu, Yezi and Feng, Wei and Shen, XiaoTong and Liu, Lei and Xu, Gang and Zhang, Zheng},
title = {TRIM6 facilitates SARS‐CoV‐2 proliferation by catalyzing the K29‐typed ubiquitination of NP to enhance the ability to bind viral genomes},
journal = {Journal of Medical Virology},
year = {2024},
volume = {96},
number = {3},
doi = {10.1002/jmv.29531}
}
EUVIMED